|
In order to view this program you must log in. If you do not have an account, please register for one.
Viewing the webcast requires use of the free RealPlayer. 
If you are having problems viewing the program, please check out our technical support section.
|
| Credits | 1.00 |
| Release Date | 9/12/2008 |
| Termination Date | 9/12/2011 |
| Cost |
$25.00 to view the program and complete a post test for CME credit. To purchase this program please log in.
|
| Description | According to the National Institutes of Health, Alpha-1 antitrypsin deficiency is an inherited disorder that can cause lung disease in adults and liver disease in adults and children.
This program is supported in part by educational grants from CSL Behring and Merck. |
| Accreditation Statement | The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Author | Charlie Strange, MD and Mark Wewers, MD |
| Objectives | Upon completion of this educational activity the participant will be able to: 1.) Describe the clinial presentation and diagnostic recommendations for alpha-1 antitrypsin deficiency (AATD). 2.) Describe the options for therapy for AATD. 3.) Explain the enormous contribution that cigarette smoking makes to alpha 1 antitrypsin deficiency. |
| Audience | This course is designed for physicians. |
| Estimated Time to Complete | 1 Hour |
